PlainRecalls
FDA Drug Moderate Class II Terminated

HYDROXO-B12 10ML PBF MDV 5MG/ML INJ, 5mg/mL, Rx only, 10 mL Glass/ Multiple Dose vial, Prepared by Key Compounding Pharmacy HYDROXO-B12 30ML PBF MDV 5MG/ML INJ, 5mg/mL, RX only, 30 mL Glass/ Multiple Dose vial.

Reported: May 24, 2017 Initiated: April 18, 2017 #D-0724-2017

Product Description

HYDROXO-B12 10ML PBF MDV 5MG/ML INJ, 5mg/mL, Rx only, 10 mL Glass/ Multiple Dose vial, Prepared by Key Compounding Pharmacy HYDROXO-B12 30ML PBF MDV 5MG/ML INJ, 5mg/mL, RX only, 30 mL Glass/ Multiple Dose vial.

Reason for Recall

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Details

Units Affected
8 vials total (6/10mL vials and 2/30 mL vials)
Distribution
Distributed nationwide in U.S.A., Australia and Canada.
Location
Federal Way, WA

Frequently Asked Questions

What product was recalled?
HYDROXO-B12 10ML PBF MDV 5MG/ML INJ, 5mg/mL, Rx only, 10 mL Glass/ Multiple Dose vial, Prepared by Key Compounding Pharmacy HYDROXO-B12 30ML PBF MDV 5MG/ML INJ, 5mg/mL, RX only, 30 mL Glass/ Multiple Dose vial.. Recalled by Key Pharmacy and Compounding Center. Units affected: 8 vials total (6/10mL vials and 2/30 mL vials).
Why was this product recalled?
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 24, 2017. Severity: Moderate. Recall number: D-0724-2017.